Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
Introduction. Diabetic population has a higher risk of colorectal cancer (CRC) incidence and mortality than nondiabetics. The role of metformin in CRC prognosis is still controversial. The meta-analysis aims to investigate whether metformin improves the survival of diabetic CRC patients. Methods. Pu...
Saved in:
Main Authors: | Fanqiang Meng, Li Song, Wenyue Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2017/5063239 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival Analysis of Diabetic Colorectal Cancer Patients on Metformin
by: Alex Brandon Wong, et al.
Published: (2023-12-01) -
Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
by: Yaodu Wang, et al.
Published: (2017-01-01) -
Impact of Physical Activity on Cancer-Specific and Overall Survival of Patients with Colorectal Cancer
by: Gaetan Des Guetz, et al.
Published: (2013-01-01) -
Patients with colorectal cancer combined with HIV had a worse overall survival after surgery: a meta-analysis
by: Wen-Wen Yang, et al.
Published: (2025-01-01) -
Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.
by: Hui Xie, et al.
Published: (2025-01-01)